ARMP
AMEX · Biotechnology
Armata Pharmaceuticals Inc
$7.70
-0.38 (-4.70%)
Open$8.11
Previous Close$8.08
Day High$8.11
Day Low$7.70
52W High$14.09
52W Low$6.73
Volume—
Avg Volume100.6K
Market Cap280.33M
P/E Ratio—
EPS$-0.65
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+126.6% upside
Current
$7.70
$7.70
Target
$17.45
$17.45
$10.78
$17.45 avg
$19.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 50.93M | 51.72M | 48.38M |
| Net Income | -16,386,219 | -16,237,176 | -12,069,043 |
| Profit Margin | -32.2% | -31.4% | -24.9% |
| EBITDA | -22,680,337 | -19,844,642 | -21,697,061 |
| Free Cash Flow | -12,782,246 | -12,228,215 | -11,985,347 |
| Rev Growth | +4.2% | -2.8% | -3.9% |
| Debt/Equity | 1.24 | 1.13 | 1.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |